Physician profile
Bryan Slepicka
NPI 1487115358
$8,674.55
in general payments reported to CMS, 2019-2025
12 companies · $4,590 in 2025
The $4,590 reported for 2025 was more than what 92% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,827 · 2024: $2,258 · 2025: $4,590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,295 · Food and Beverage: $3,245 · Education: $1,135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,294.68 |
| Food and Beverage | $3,245.07 |
| Education | $1,134.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,283.52 | 2024-2025 | General - Therapies, Superion Indirect Decompression System, Intracept |
| Saluda Medical Americas, INC. | $2,213.11 | 2024-2025 | Evoke |
| Nevro Corp. | $1,812.42 | 2023 | Senza |
| Spr Therapeutics, INC | $613.19 | 2024-2025 | Sprint Pns System |
| Abbott Laboratories | $302.93 | 2024-2025 | Proclaim, Eterna, Swift-Lock |
| Medtronic, INC. | $137.70 | 2024 | Intellis Adaptivestim |
| Curonix LLC | $90.60 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Globus Medical, INC. | $78.14 | 2025 | Senza |
| Convatec INC. | $63.07 | 2025 | |
| Abbvie INC. | $45.35 | 2025 | |
| Braeburn INC. | $20.01 | 2024 | Brixadi |
| Edwards Lifesciences Corporation | $14.51 | 2023 | Hemosphere |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Slepicka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.